Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has selected CFTX-2034, an SSTR5 agonist, as its new antibody ...

BioNTech has completed its exchange offer to acquire CureVac Acquisition complements BioNTech’s capabilities and proprietary technologies in mRNA design, delivery formulations, and mRNA manufacturing ...

Copies of the AGM documents, along with the Company's Annual Report for the year ended 30 April 2025, are available for download from the Company's website ...

Dr. Günther combines a rare blend of medical innovation and technology leadership and a proven track record as a biotech entrepreneur, scaling sustainable cell therapy businesses from startup to exit.

FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting the DNA Damage Response in treatment-resistant cancers. Its lead product ...

Sofio uses patented magnetohydrodynamics (MHD) to draw a micro-sample of interstitial fluid through skin, where glucose is measured using established glucose oxidase enzyme chemistry, the same method ...

Paris, France and London, United Kingdom (18 December 2025) – EssilorLuxottica and Burberry today announced the renewal of their licensing agreement for the development, production and global ...

The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, reports that it has suffered ...

Strengthens DSR patent protection based upon extensive clinical and pre-clinical experience Data published in European Journal of Heart Failure supports DSR as breakthrough in treatment of cardiorenal ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New Drug ...

Three of the biotech industry’s trusted advisory firms: KreaMedica, Venture Valuation, and Lacerta Bio, today announced the release of The First-Time Biotech CEO Playbook, a practical guide designed ...

Sapu BioScience has been developing TGFB2-targeted antisense therapeutics, establishing one of the deepest proprietary knowledge bases around this pathway in oncology. That work has generated a broad ...